Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 02, 2025 23:45 ET | Source: Vantage Drilling International

Correction: Vantage Drilling International Ltd. – Key information relating to the cash dividend to be paid

Dubai, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The board of directors of Vantage Drilling International Ltd. on 1 December 2025 resolved to distribute a dividend. The key dates have been corrected as...
December 01, 2025 11:12 ET | Source: Vantage Drilling International

Vantage Drilling International Ltd. – Key information relating to the cash dividend to be paid

Dubai, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The board of directors of Vantage Drilling International Ltd. has on 1 December 2025 resolved to distribute a dividend as summarised below. The shares will...
December 01, 2025 11:10 ET | Source: Vantage Drilling International

Vantage Drilling International Ltd. – Board declares dividend of USD 5 per share

Dubai, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Vantage Drilling International Ltd. (the "Company", ticker VDI) announces that the Company's board of directors has resolved a cash dividend payment of USD 5...
November 27, 2025 08:58 ET | Source: Research and Markets

CD40 Agonists and CD40/L Antagonists Pipeline and Competitive Intelligence Report 2025

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of CD40 Agonists and CD40/L Antagonists" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report...
November 27, 2025 08:54 ET | Source: Research and Markets

Interleukin-6 (IL-6) Receptor Antagonists and IL6- Inhibitors Competitive Intelligence Report 2025: Launch of the First Tocilizumab Biosimilar Antibodies Highlights the Attractiveness of the Market

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of Interleukin-6 (IL-6) Receptor Antagonists and IL6- Inhibitors" report has been added to ResearchAndMarkets.com's offering.This competitive...
November 27, 2025 08:47 ET | Source: Research and Markets

CD73 Inhibitors Pipeline Report 2025: an Up-to-date Competitor Evaluation in the Field of Antibodies, RNA and Small Molecules in Research and Development Inhibiting CD73

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of CD73 Inhibitors" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about CD73 Inhibitors...
November 27, 2025 08:45 ET | Source: Research and Markets

NaPi2b-Targeted Immunotherapies Pipeline and Competitive Intelligence Report 2025

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of NaPi2b-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
November 27, 2025 08:43 ET | Source: Research and Markets

KLK2-Targeted Immunotherapies Pipeline Competitive Intelligence Report 2025

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of KLK2-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
November 27, 2025 08:42 ET | Source: Research and Markets

STEAP1- and STEAP2-Targeted Immunotherapies Pipeline and Competitive Intelligence Report 2025

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of STEAP1- and STEAP2-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence...
November 27, 2025 08:40 ET | Source: Research and Markets

Tissue Factor-Targeted Immunotherapies Pipeline and Competitive Intelligence Report 2025: Tivdak Has Become the Benchmark for Improved Next Generation ADCs in Non-clinical and Clinical Development

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of Tissue Factor-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report...